Repeated sampling offers insight into glioblastoma therapy response
A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass…
AI tool accurately distinguishes between glioblastoma and primary central nervous system lymphoma
A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike…
‘Rogue’ DNA rings identified as drivers of aggressive brain cancer
An international team of scientists has revealed how rogue rings of DNA that float outside of our chromosomes…